Wright Medical Group, Inc. (WGMI) Receives Department of Defense Funding for Clinical Study of OSTEOSET(R) T Bone Graft Substitute in Combat-Related Open Fracture Wounds  
10/5/2010 11:32:50 AM

ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, today announced it has been awarded a $2.4 million grant from the United States Department of Defense to fund a clinical study of OSTEOSET® T bone graft substitute pellets in combat-related open fracture wounds.